Aims
====

The European Society of Urogenital Radiology (ESUR) prostate imaging-reporting and data system (PI-RADS) standardises reporting of multiparametric (MP) prostate cancer MRI. At our uro-oncology centre there has been a shift to using PI-RADS/MP MRI prior to transrectal ultrasound-guided biopsy (TRUSGB). We aim to assess the efficacy of using PI-RADS in targeted TRUSGB.

Methods
=======

A retrospective review was performed on 50 consecutive patients who underwent prostate MRI and subsequent TRUSGB between January-March 2015. Data were collected from MRI reports/PI-RADS to score lesion level of suspicion and location, which was correlated to Gleason grading from histology obtained through TRUSGB. Analysis and basic statistics were performed.

Results
=======

Histology was positive for high-grade cancer in 27/50 patients. Lesions deemed to be suspicious for cancer (PI-RADS score 4 and 5) had a positive predictive value of 83% (25/30), and were located correctly in 88%. Lesions deemed to be benign (PI-RADS score 1/2) had a negative predictive value of 80% (8/10). Equivocal lesions (PI-RADS score 3) were histologically higher grade (Gleason 3+4 and greater) in 30% (3/10), Gleason 3+3 in 10% (1/10) and negative in 60% (6/10). The overall sensitivity/specificity was 93%/62% respectively.

Conclusion
==========

In this sample of patients, the use of PI-RADS on prebiopsy prostate MRI has shown to have a high sensitivity and high positive predictive value in detecting/localising prostate cancer, which makes it a useful tool for targeting biopsy and detection. Going forward the high sensitivity would also have implications on the more selective use of TRUSGB.
